Outcome and prognostic factors in cervical cancer patients treated with surgery and concurrent chemoradiotherapy: a retrospective study
- PMID: 29378625
- PMCID: PMC5789695
- DOI: 10.1186/s12957-017-1307-0
Outcome and prognostic factors in cervical cancer patients treated with surgery and concurrent chemoradiotherapy: a retrospective study
Abstract
Background: The objective of this study is to analyze the treatment outcome and secondary reactions in 98 patients with stage I-III cervical carcinoma who underwent postoperative radiotherapy.
Methods: From 2006 to 2014, 98 patients with stage I-III cervical carcinoma were treated with postoperative radiotherapy. The major histological type, found in 92.86% of the patients (91 cases), was squamous cell carcinoma. Patients were staged according to the 2002 TNM guidelines. The postoperative radiotherapy methods included two-field irradiation (16 patients, 16.32%), four-field box irradiation (16 patients, 16.32%), and intensity-modulated radiotherapy (IMRT; 66 patients, 67.36%). The survival rates were represented using Kaplan-Meier curves, and prognosis analyses were performed using Cox multivariate analyses.
Results: The 5-year overall survival and progression-free survival rates were 82.0 and 76.0%, respectively. Only one patient (1.02%) developed a grade 3 acute radiation enteritis, while grade 3 and 4 myelosuppression was noted in 17 patients (17.35%) and one patient (1.02%), respectively. Multivariate analyses showed that anemia before radiotherapy and tumor size were predictors of the OS (P = 0.008, P = 0.045) rates.
Conclusions: Postoperative radiotherapy for patients with risk factors of cervical cancer procured good efficacy levels with mild side effects. Anemia and tumor size were important OS predictors.
Keywords: Cervical carcinoma; Chemoradiotherapy; Postoperative radiotherapy; Prognosis.
Conflict of interest statement
Ethics approval and consent to participate
This study was approved by the ethical committee of Tai Zhou Central Hospital.
Consent for publication
Written informed consent was obtained from the patient for publication of this report and the accompanying images.
Competing interests
The authors declare that they have no competing interests.
Publisher’s Note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Figures
Similar articles
-
[Analysis of prognostic factors and therapeutic patterns of recurrent stage Ⅰb-Ⅱa cervical squamous carcinoma treated with radical hysterectomy].Zhonghua Fu Chan Ke Za Zhi. 2019 Jun 25;54(6):399-405. doi: 10.3760/cma.j.issn.0529-567x.2019.06.008. Zhonghua Fu Chan Ke Za Zhi. 2019. PMID: 31262124 Chinese.
-
The prognostic factors for locally advanced cervical cancer patients treated by intensity-modulated radiation therapy with concurrent chemotherapy.J Formos Med Assoc. 2015 Mar;114(3):231-7. doi: 10.1016/j.jfma.2012.10.021. Epub 2013 Jan 5. J Formos Med Assoc. 2015. PMID: 25777974
-
Clinical experience of pelvic radiotherapy or chemoradiotherapy for postoperative uterine cervical cancer using intensity-modulated radiation therapy.J Radiat Res. 2020 May 22;61(3):470-478. doi: 10.1093/jrr/rraa004. J Radiat Res. 2020. PMID: 32100833 Free PMC article.
-
[Curative effect analysis of postoperative concurrent chemoradiotherapy on early-stage cervical cancer patients with intermediate-risk factors].Zhonghua Zhong Liu Za Zhi. 2018 Jun 23;40(6):462-466. doi: 10.3760/cma.j.issn.0253-3766.2018.06.012. Zhonghua Zhong Liu Za Zhi. 2018. PMID: 29936774 Chinese.
-
Survival of Patients With Cervical Cancer Treated With Definitive Radiotherapy or Concurrent Chemoradiotherapy According to Histological Subtype: A Systematic Review and Meta-Analysis.Front Med (Lausanne). 2022 Mar 1;9:843262. doi: 10.3389/fmed.2022.843262. eCollection 2022. Front Med (Lausanne). 2022. PMID: 35299841 Free PMC article.
Cited by
-
Morphological Characteristics and Clinical Significance of Different Types of Tumor Vessels in Patients with Stages I-IIA of Squamous Cervical Cancer.J Oncol. 2020 Aug 12;2020:3818051. doi: 10.1155/2020/3818051. eCollection 2020. J Oncol. 2020. PMID: 32849870 Free PMC article.
-
High RPS27A Expression Predicts Poor Prognosis in Patients With HPV Type 16 Cervical Cancer.Front Oncol. 2021 Nov 2;11:752974. doi: 10.3389/fonc.2021.752974. eCollection 2021. Front Oncol. 2021. PMID: 34796111 Free PMC article.
-
Expression Level of lncRNA CYTOR in Iranian Cervical Cancer Patients.Rep Biochem Mol Biol. 2023 Apr;12(1):120-126. doi: 10.52547/rbmb.12.1.120. Rep Biochem Mol Biol. 2023. PMID: 37724154 Free PMC article.
-
High M2-TAM Infiltration and STAT3/NF-κB Signaling Pathway as a Predictive Factor for Tumor Progression and Death in Cervical Cancer.Cancers (Basel). 2024 Jul 9;16(14):2496. doi: 10.3390/cancers16142496. Cancers (Basel). 2024. PMID: 39061137 Free PMC article.
-
Long non-coding RNA RP11-480I12.5 promotes cervical carcinoma progression by regulating the Wnt/β-catenin signaling pathway.Oncol Lett. 2020 Jan;19(1):469-475. doi: 10.3892/ol.2019.11120. Epub 2019 Nov 19. Oncol Lett. 2020. PMID: 31897160 Free PMC article.
References
-
- J. Ferlay, I. Soerjomataram, R. Dikshit, et al.Cancer incidence and mortality worldwide: sources, methods and major patterns in GLOBOCAN 2012, Int. J.Cancer 136 (2015) E359-E386. - PubMed
-
- Ohara K, Sugahara S, Kagei K, Hata M, Igaki H, Tokuuye K, et al. Retrospective comparison of clinical outcome between radiotherapy alone and surgery plus postoperative radiotherapy in the treatment of stages IB-IIB cervical squamous cell carcinoma. Radiat Med. 2004;22:42–48. - PubMed
-
- Peters WA, 3rd, Liu PY, Barrett RJ, 2nd, Stock RJ, Monk BJ, Berek JS, et al. Concurrent chemotherapy and pelvic radiation therapy compared with pelvic radiation therapy alone as adjuvant therapy after radical surgery in high-risk early-stage cancer of the cervix. J Clin Oncol. 2000;18:1606–1613. doi: 10.1200/JCO.2000.18.8.1606. - DOI - PubMed
Publication types
MeSH terms
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical